Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.6/5
Green Cross LabCell (144510 KS)
Watchlist
15
Analysis
Health Care
•
South Korea
Green Cross LabCell Corp. is a biotechnology company that researches and develops cell therapy products. The Company is also engaged in cell banking, clinical laboratory services, clinical trial, and bio-logistics services.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Solid Inc
•
27 May 2025 22:41
KOSDAQ150 Index Rebalance: 9 Changes as Fadu Ignored Again
There are 9 changes as Fadu and Joongang AM have been kept out of the index again. Passive impact varies from 0.2-8.6x ADV. Performance has been...
Brian Freitas
Follow
533 Views
Share
bearish
•
Cross Asset Strategy
•
27 May 2025 11:56
KOSPI 200 and KOSDAQ 150 Constituent Changes Announced: A Few Surprises
Korea Exchange announced its KOSPI200 rebalance changes on 27 May. It added 8 companies and deleted 8 companies. KRX also added 9 companies and...
Douglas Kim
Follow
265 Views
Share
bullish
•
Sung Kwang Bend
•
21 May 2025 00:06
KOSDAQ150 Index Rebalance Preview: Announcement Around the Corner
We highlight 11 potential changes for the index in June. Impact varies from 0.2-7.5x ADV. The forecast adds have outperformed the forecast deletes...
Brian Freitas
Follow
504 Views
Share
bearish
•
Quantitative Analysis
•
15 Apr 2025 23:00
KRX Short Interest Weekly (Apr 11th): Lg Energy Solution, Sk Innovation, Hanmi Semi
We analyzed KRX short interest report for the past week and highlighted short interest changes in Lg Energy Solution, Sk Innovation, Hanmi Semi, Hd...
Ke Yan, CFA, FRM
Follow
350 Views
Share
bullish
•
Quantitative Analysis
•
26 Mar 2025 02:46
KRX Short Interest Weekly (Mar 21st): Mobis, Korea Aerospace
We analyzed KRX short interest report for the past week and highlighted short interest changes in Mobis, Korea Aerospace.
Ke Yan, CFA, FRM
Follow
237 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x